Mechanisms regulating macrophage-induced nitric oxide production by spontaneously transformed hamster fibroblasts

Journal of Leukocyte Biology

Volumn 60, Issue 4, 1996, Pages 473-479

  Lavnikova, Natasha ^b   Prokhorova, Svetlana ^b   Burdelia, Ludmila ^a   Lakhotia, Anand ^b   Laskin, Debra L ^b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Alveolar macrophages; Interleukin 1; Lipopolysaccharide; Tumor cells; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; N(G) METHYLARGININE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; CRICETINAE;

EID: 0029957563     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.60.4.473     Document Type: Article

References (30)

1. Hibbs, J. B., Jr., Vavrin, Z., Taintor, R. (1987) L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138, 550-565.
2. Stuehr, D. J., Nathan, C. F. (1989) Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169, 1543-1555.
3. Keller, R., Geiges, M., Keist, R. (1990) L-arginine-dependent reactive nitrogen intermediates as mediators of tumor ceil killing by activated macrophages. Cancer Res. 50, 1421-1425.
4. Kwon, N. S., Stuehr, D. J., Nathan, C. F. (1991) Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 174, 761-767.
5. Lavnikova, N., Drapier, J.-C., Laskin, D. L. (1993) A single exogenous stimulus activates resident rat macrophages for nitric oxide production and tumor cytotoxicity. J. Leukoc. Biol. 54, 322-328.
6. Amber, I. J., Hibbs, J. B., Jr., Taintor, R. R., Vavrin, Z. (1988) Cytokines induce an L-arginine-dependent effector system in non-macrophage cells. J. Leukoc. Biol. 44, 58-65.
7. Dong, Z., Staroselsky, A. H., Qi, X., Xie, K., Fidler, I. J. (1994) Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res. 54, 789-793.
8. Xie, K., Huang, S., Dong, Z., Juang, S. H., Gutman, M., Xie, Q., Nathan, C., Fidler, I. J. (1995) Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181, 1333-1343.
9. Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K. (1995) Role of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA 92, 4392-4396.
10. Radomski, M. W., Jenkins, D. C., Holmes, L., Moncada, S. (1991) Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res. 51, 6073-6078.
11. Deichman, G. I., Vendrov, E. L. (1986) Characteristics of in vitro transformed cells essential for their in vivo survival, selection and metastasizing activity. Int. J. Cancer 37, 401-409.
12. Deichman, G. I., Kluchareva, T. E., Matveeva, V. A., Kushlinsky, N. E., Bassalyk, L. S., Vendrov, E. L. (1989) Clustering of discrete cell properties essential for tumorgenicity and metastasis: studies of Syrian hamster embryo fibroblasts spontaneously transformed in vitro. Int. J. Cancer 44, 904-907.
13. Deichman, G. I., Kashleva, H. A., Kluchareva, T. E., Matveeva, V. A. (1989) Clustering of discrete cell properties essential for tumorigenicity and metastasis: studies of Syrian hamster embryo fibroblasts transformed by Rous sarcoma virus. Int. J. Cancer 44, 908-910.
14. Deichman, G. I., Gurova, K. V., Dyakova, N. A. (1994) Accumulation in "normal" lungs of live tumorigenic cells during sub-cutaneous growth of weakly and highly metastasizing tumors and their in vitro sensitivity to growth regulation by normal fibroblasts. Int. J. Cancer 59, 530-537.
15. Drapier, J.-C., Hibbs, J. B. (1988) Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in l-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immunol. 140, 2829-2838.
16. Kurt-Jones, E. A., Beller, D. I., Mizel, S. B., Unanue, E. R. (1985) Identification of membrane-associated interleukin 1 in macrophages. Proc. Natl. Acad. Sci. USA 82, 1204-1208.
17. Hasday, J. D., Shah, E. M., Lieberman, A. P. (1990) Macrophage tumor necrosis factor-α release is induced by contact with some tumors. J. Immunol. 145, 371-379.
18. DeMarco, R., Ensor, J. E., Masday, J. D. (1992) Tumor-stimulated release of tumor necrosis faclor-α by human monocyte-derived macrophages. Cell. Immunol. 140, 304-318.
19. Lavnikova, N., Lakhotia, A., Patel, N., Prokhorova, S., Laskin, D. L. Cytostasis is required for IL-1 induced nitric oxide production in transformed hamster fibroblasts. J. Cell Physiol., in press.
20. Isobe, K. I., Nakashima, I. (1993) Abundant production of nitric oxide from murine macrophages by direct stimulation of tumor cells. Biochem. Biophys. Res. Commun. 192, 499-504.
21. Zembala, M., Siedlar, M., Marcinkiewcz, J., Pryjma, J. (1994) Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur. J. Immunol. 24, 435-439.
22. Jiang, H., Stewart, C. A., Fast, D. J., Leu, R. W. (1992) Tumor target-derived soluble factor synergizes with IFN-γ and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. J. Immunol. 149, 2137-2146.
23. Sodhi, A., Shrivastava, A., Kumar, R. (1995) Induction of protein tyrosine phosphorylation in macrophages incubated with tumor cells. Biochem. Mol. Biol. Int. 35, 559-565.
24. Schneemann, M., Schoedon, G., Hofer, S., Blau, N., Guerrero, L., Schaffner, A. (1993) Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167, 1358-1363.
25. Gery, I., Davies, P., Derr, J., Krett, N., Barranger, J. A. (1981) Relationship between production and release of lymphocyte-activating factor (inlerleukin-1) by murine macrophages. 1. Effects of various agents. Cell. Immunol. 64, 293-303.
26. Hogquist, K. A., Unanue, R. R., Chaplin, D. D. (1991) Release of IL-1 from mononuclear phagocytes. J. Immunol. 147, 2181-2186.
27. Le, J., Weinstein, D., Gubler, U., Vilcek, J. (1987) Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts. J. Immunol. 138, 2137-2142.
28. Reis, L. F. L., Lee, T. H., Vilcek, J. (1989) Tumor necrosis factor acts synergistically with autocrine interferon-γ and increases interferon-γ mRNA levels in human fibroblasts. J. Biol. Chem. 264, 16351-16354.
29. Suttles, J., Carruth, L. M., Mizel, S. B. (1990) Detection of IL-1a and IL-1β in the supernatants of paraformaldehyde-treated human monocytes. Evidence against a membrane form of IL-1. J. Immunol. 144, 170-174.
30. Hogquist, K. A., Nett, M. A., Unanue, E. R., Chaplin, D. D. (1991) Interleukin 1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. USA 88, 8485-8489.